Follow the Fredun Pharma share price and the full insider trade history of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Fredun Pharma has recorded 1 insider filings. Market capitalisation: €17.4bn. The latest transaction was filed on 15 May 2026 (Acquisition). Among the most active insiders: Fredun Nariman Medhora & Others. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Fredun Pharma 是一家专注于健康和制药领域的公司。该公司在 XBOM 市场上市。